# Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects

## Metadata
**Authors:** Yoshiharu Suzuki, Masato Homma, Kosuke Doki, Fumio Itagaki, Yukinao Kohda
**Journal:** British Journal of Clinical Pharmacology
**Date:** 2008 Mar 13
**DOI:** [10.1111/j.1365-2125.2008.03162.x](https://doi.org/10.1111/j.1365-2125.2008.03162.x)
**PMID:** 18341670
**PMCID:** PMC2485247
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2485247/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC2485247/pdf/bcp0066-0154.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC2485247/pdf/bcp0066-0154.pdf)

## References

1. Kawai S, Yamamoto K. Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology. 2006;45:441–4. doi: 10.1093/rheumatology/kei172.  [DOI](https://doi.org/10.1093/rheumatology/kei172) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16263777/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Rheumatology&title=Safety%20of%20tacrolimus,%20an%20immunosuppressive%20agent,%20in%20the%20treatment%20of%20rheumatoid%20arthritis%20in%20elderly%20patients&author=S%20Kawai&author=K%20Yamamoto&volume=45&publication_year=2006&pages=441-4&pmid=16263777&doi=10.1093/rheumatology/kei172&)

2. Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther. 2006;80:331–45. doi: 10.1016/j.clpt.2006.06.008.  [DOI](https://doi.org/10.1016/j.clpt.2006.06.008) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17015051/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=Population%20pharmacokinetic%20and%20pharmacogenomic%20analysis%20of%20tacrolimus%20in%20pediatric%20living-donor%20liver%20transplant%20recipients&author=M%20Fukudo&author=I%20Yano&author=S%20Masuda&author=M%20Goto&author=M%20Uesugi&volume=80&publication_year=2006&pages=331-45&pmid=17015051&doi=10.1016/j.clpt.2006.06.008&)

3. Choi JH, Lee YJ, Jang SB, Lee JE, Kim KH, Park K. Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. Br J Clin Pharmacol. 2007;64:185–91. doi: 10.1111/j.1365-2125.2007.02874.x.  [DOI](https://doi.org/10.1111/j.1365-2125.2007.02874.x) | [PMC free article](/articles/PMC1974827/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17391324/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&title=Influence%20of%20the%20CYP3A5%20and%20MDR1%20genetic%20polymorphisms%20on%20the%20pharmacokinetics%20of%20tacrolimus%20in%20healthy%20Korean%20subjects&author=JH%20Choi&author=YJ%20Lee&author=SB%20Jang&author=JE%20Lee&author=KH%20Kim&volume=64&publication_year=2007&pages=185-91&pmid=17391324&doi=10.1111/j.1365-2125.2007.02874.x&)

4. Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA. Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther. 1995;57:281–90. doi: 10.1016/0009-9236(95)90153-1.  [DOI](https://doi.org/10.1016/0009-9236(95)90153-1) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/7535213/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=Pharmacokinetics%20of%20tacrolimus%20in%20liver%20transplant%20patients&author=WJ%20Jusko&author=W%20Piekoszewski&author=GB%20Klintmalm&author=MS%20Shaefer&author=MF%20Hebert&volume=57&publication_year=1995&pages=281-90&pmid=7535213&doi=10.1016/0009-9236(95)90153-1&)

5. van Schaik RH, van der Heiden IP, van den Anker JN, Lindemans J. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem. 2002;48:1668–71.  [PubMed](https://pubmed.ncbi.nlm.nih.gov/12324482/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&title=CYP3A5%20variant%20allele%20frequencies%20in%20Dutch%20Caucasians&author=RH%20van%20Schaik&author=IP%20van%20der%20Heiden&author=JN%20van%20den%20Anker&author=J%20Lindemans&volume=48&publication_year=2002&pages=1668-71&pmid=12324482&)

6. Qian W, Homma M, Itagaki F, Tachikawa H, Kawanishi Y, Mizukami K, Asada T, Inomata S, Honda K, Ohkohchi N, Kohda Y. MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression. Biol Pharm Bull. 2006;29:2446–50. doi: 10.1248/bpb.29.2446.  [DOI](https://doi.org/10.1248/bpb.29.2446) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17142980/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Biol%20Pharm%20Bull&title=MDR1%20gene%20polymorphism%20in%20Japanese%20patients%20with%20schizophrenia%20and%20mood%20disorders%20including%20depression&author=W%20Qian&author=M%20Homma&author=F%20Itagaki&author=H%20Tachikawa&author=Y%20Kawanishi&volume=29&publication_year=2006&pages=2446-50&pmid=17142980&doi=10.1248/bpb.29.2446&)

7. Takane H, Kobayashi D, Hirota T, Kigawa J, Terakawa N, Otsubo K, Ieiri I. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J Pharmacol Exp Ther. 2004;311:1179–87. doi: 10.1124/jpet.104.069724.  [DOI](https://doi.org/10.1124/jpet.104.069724) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15280437/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Pharmacol%20Exp%20Ther&title=Haplotype-oriented%20genetic%20analysis%20and%20functional%20assessment%20of%20promoter%20variants%20in%20the%20MDR1%20(ABCB1)%20gene&author=H%20Takane&author=D%20Kobayashi&author=T%20Hirota&author=J%20Kigawa&author=N%20Terakawa&volume=311&publication_year=2004&pages=1179-87&pmid=15280437&doi=10.1124/jpet.104.069724&)

8. Li D, Lu W, Zhu JY, Gao J, Lou YQ, Zhang GL. Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients. J Clin Pharm Ther. 2007;32:505–15. doi: 10.1111/j.1365-2710.2007.00850.x.  [DOI](https://doi.org/10.1111/j.1365-2710.2007.00850.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17875118/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Pharm%20Ther&title=Population%20pharmacokinetics%20of%20tacrolimus%20and%20CYP3A5,%20MDR1%20and%20IL-10%20polymorphisms%20in%20adult%20liver%20transplant%20patients&author=D%20Li&author=W%20Lu&author=JY%20Zhu&author=J%20Gao&author=YQ%20Lou&volume=32&publication_year=2007&pages=505-15&pmid=17875118&doi=10.1111/j.1365-2710.2007.00850.x&)
